Abstract
Idiopathic pulmonary alveolar proteinosis is presumed to be an autoimmune disorder that may lead to pulmonary insufficiency. However, steroids do not appear to be effective and the standard of therapy is whole-lung lavage. We report the first case of successful therapy with rituximab, which addresses the pathogenic mechanism of pulmonary alveolar proteinosis. Copyright©ERS Journals Ltd 2009.
Author supplied keywords
Cite
CITATION STYLE
APA
Borie, R., Debray, M. P., Laine, C., Aubier, M., & Crestani, B. (2009). Rituximab therapy in autoimmune pulmonary alveolar proteinosis. European Respiratory Journal, 33(6), 1503–1506. https://doi.org/10.1183/09031936.00160908
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free